• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Drug resistance after failure of initial antiretroviral therapy in resource-limited countries.

作者信息

Gallant Joel E

出版信息

Clin Infect Dis. 2007 Feb 1;44(3):453-5. doi: 10.1086/510752. Epub 2006 Dec 27.

DOI:10.1086/510752
PMID:17205458
Abstract
摘要

相似文献

1
Drug resistance after failure of initial antiretroviral therapy in resource-limited countries.资源有限国家初始抗逆转录病毒治疗失败后的耐药性
Clin Infect Dis. 2007 Feb 1;44(3):453-5. doi: 10.1086/510752. Epub 2006 Dec 27.
2
Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.对于接受司他夫定、拉米夫定和奈韦拉平固定剂量联合初始治疗方案失败的1型人类免疫缺陷病毒（HIV-1）感染患者，二线抗逆转录病毒治疗方案的选择。
Clin Infect Dis. 2007 Feb 1;44(3):447-52. doi: 10.1086/510745. Epub 2006 Dec 27.
3
HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen.使用通用型固定剂量复方司他夫定/拉米夫定/奈韦拉平作为标准一线治疗方案后的HIV耐药性。
AIDS. 2007 Nov 12;21(17):2341-3. doi: 10.1097/QAD.0b013e328235a527.
4
Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.中国福建省流行的HIV-1 CRF01_AE毒株的多态性与耐药性分析
Arch Virol. 2007;152(10):1799-805. doi: 10.1007/s00705-007-1019-9. Epub 2007 Jul 6.
5
First-line antiretroviral therapy in resource-limited settings: time to reconsider?资源有限环境下的一线抗逆转录病毒疗法：是时候重新考虑了吗？
J Infect Dis. 2009 May 1;199(9):1407; author reply 1407-8. doi: 10.1086/597809.
6
Performance of a World Health Organization first-line regimen (stavudine/lamivudine/nevirapine) in antiretroviral-naïve individuals in a Western setting.世界卫生组织一线治疗方案（司他夫定/拉米夫定/奈韦拉平）在西方环境中初治抗逆转录病毒治疗个体中的疗效。
HIV Med. 2007 Jul;8(5):267-70. doi: 10.1111/j.1468-1293.2007.00463.x.
7
HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.接受基于非核苷类逆转录酶抑制剂的抗逆转录病毒治疗失败的儿童中的HIV-1耐药性突变
Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):83-8.
8
Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.喀麦隆一组感染1型艾滋病毒患者在接受一线抗逆转录病毒治疗方案不同疗程后的耐药情况。
Antivir Ther. 2009;14(3):339-47.
9
Long-term efficacy of a protease inhibitor-sparing, nucleoside reverse transcriptase inhibitor-limiting antiretroviral regimen with nevirapine, lamivudine, and reduced standard stavudine dosage.一种含奈韦拉平、拉米夫定及降低标准司他夫定剂量的、节省蛋白酶抑制剂并限制核苷类逆转录酶抑制剂的抗逆转录病毒治疗方案的长期疗效。
HIV Clin Trials. 2004 Jan-Feb;5(1):62-4. doi: 10.1310/11PP-PG9W-FUJT-64YL.
10
Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense.在资源有限的环境中提供安全的抗逆转录病毒疗法：简化流程以尽量减少耐药性和费用。
HIV Med. 2008 Oct;9(8):636-41. doi: 10.1111/j.1468-1293.2008.00611.x. Epub 2008 Jul 17.

引用本文的文献

1
Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil.巴西里约热内卢一项队列研究：HIV感染患者二线联合抗逆转录病毒治疗的结果
BMC Infect Dis. 2014 Dec 19;14:699. doi: 10.1186/s12879-014-0699-5.
2
Optimizing treatment switch for virologic failure during first-line antiretroviral therapy in resource-limited settings.在资源有限的环境中，优化一线抗逆转录病毒治疗期间病毒学失败的治疗转换。
J Int Assoc Provid AIDS Care. 2013 Jul-Aug;12(4):236-40. doi: 10.1177/1545109712463733. Epub 2012 Nov 5.
3
Antiretroviral therapy in Indian setting: when & what to start with, when & what to switch to?
印度环境下的抗逆转录病毒治疗：何时开始、用什么开始，何时转换、转换为什么？
Indian J Med Res. 2011 Dec;134(6):787-800. doi: 10.4103/0971-5916.92626.
4
Predictors of Virologic Failure in HIV/AIDS Patients Treated with Highly Active Antiretroviral Therapy in Brasília, Brazil During 2002-2008.2002年至2008年期间在巴西巴西利亚接受高效抗逆转录病毒治疗的艾滋病毒/艾滋病患者病毒学失败的预测因素
Drug Target Insights. 2011;5:33-41. doi: 10.4137/DTI.S7527. Epub 2011 Nov 24.
5
Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings.免疫标准是对病毒学结果的不良预测指标：对资源有限环境下的 HIV 治疗监测的影响。
Clin Infect Dis. 2011 Dec;53(12):1283-90. doi: 10.1093/cid/cir729.
6
Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa.南非抗逆转录病毒推广项目中延迟治疗转换为二线治疗的早期结果及病毒学效应
Antivir Ther. 2011;16(6):853-61. doi: 10.3851/IMP1819.
7
High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia.在柬埔寨金边的 ESTHER/Calmette 医院进行 24 个月随访后，洛匹那韦/利托那韦为基础的二线抗逆转录病毒治疗具有高疗效。
J Int AIDS Soc. 2011 Mar 26;14:14. doi: 10.1186/1758-2652-14-14.
8
Safety, Tolerability, and Efficacy of Second-Line Generic Protease Inhibitor Containing HAART after First-Line Failure among South Indian HIV-Infected Patients.印度南部HIV感染患者一线治疗失败后含二线通用蛋白酶抑制剂的高效抗逆转录病毒治疗的安全性、耐受性和疗效
J Int Assoc Physicians AIDS Care (Chic). 2011 Mar-Apr;10(2):71-5. doi: 10.1177/1545109710382780. Epub 2011 Jan 24.
9
Antiretroviral therapy as HIV prevention: status and prospects.抗逆转录病毒疗法作为 HIV 预防：现状与展望。
Am J Public Health. 2010 Oct;100(10):1867-76. doi: 10.2105/AJPH.2009.184796. Epub 2010 Aug 19.
10
Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy.适用于一线抗逆转录病毒治疗失败的HIV患者的抗逆转录病毒治疗方案。
Cochrane Database Syst Rev. 2010 Jun 16(6):CD006517. doi: 10.1002/14651858.CD006517.pub3.